Novartis Korea to expand free coverage for Lucentis

Novartis Korea says it has expanded the scope of its patient assistance program for Lucentis (ranibizumab injection) for the treatment of neovascular (wet) age-related macular degeneration (AMD).

The company plans to provide more expanded assistance to eligible patients who cannot access needed medical treatment due to their inability to pay. Patients must meet financial and other program sp...